Core Viewpoint - The company, Sichuan Sike Rui Microelectronics Co., Ltd., has been involved in financial fraud shortly after its IPO, leading to significant regulatory penalties and a drastic decline in its financial performance [2][3][4]. Financial Fraud - In September 2025, the company was officially renamed "ST Sike Rui," revealing its financial manipulation practices that inflated revenue and profits during its first year of listing [2]. - The Sichuan Securities Regulatory Bureau issued a notice detailing the company's fraudulent activities in 2022, which included fabricating sales, prematurely recognizing revenue, and improper income recognition, resulting in inflated revenue of 9.96 million and inflated profit of 7.01 million, accounting for 4.16% and 6.56% of the respective metrics [3]. - Specific fraudulent actions included generating 3.37 million in detection revenue without actual services and recognizing 2.47 million in revenue before delivering goods, despite disputes with clients [3][4]. Regulatory Actions - The company received a warning and a fine of 2 million, with penalties imposed on several executives, including 1.2 million on the vice president for orchestrating the fraud [4]. - The leniency in handling the executives raised concerns about the company's commitment to rectifying its issues [4]. Performance Decline - The company's financial performance deteriorated sharply post-IPO, with revenue growth of only 4.87% in 2022 despite fraudulent activities, and a net profit decline of 5.77% [5]. - By 2023, revenue fell by 13.75% to 201 million, and net profit halved to 47.84 million, with further declines in 2024 leading to a loss of 210 million [5][6]. Operational Challenges - The company's gross margin decreased from a high level to 36.3% by the end of 2024, with net profit margins turning negative [6]. - The core business, primarily military electronic component reliability testing, faced significant revenue drops, with military client income plummeting by 62.99% [6][7]. Strategic Missteps - The company engaged in aggressive expansion post-IPO, investing over 20.52 million in new testing capabilities, but failed to convert this into competitive advantage, leading to increased operational costs [7]. - Management instability, including the resignation of the general manager and subsequent leadership changes, further exacerbated the company's strategic challenges [7]. Industry Context - The military detection industry is characterized by high dependency on government budgets and pricing controls, making it vulnerable to trust issues and market fluctuations [10]. - The company's loss of credibility could jeopardize its military testing qualifications, which are critical for its survival in the industry [8][9].
思科瑞上市首年即造假,这家A股军工检测企业还值得投资吗?